Meet Acumetis at MAPS EMEA 2026
Connect with our medical affairs team
Sponsor: May 17–19, 2026 | Zurich, Switzerland
Acumetis will be attending and sponsoring MAPS EMEA 2026 in Zurich. Our Medical Affairs team will be on-site to engage with industry leaders and discuss how organizations are advancing scientific strategy and execution in practice.
Connecting strategy to outcomes in medical affairs
Medical Affairs is increasingly expected to bridge scientific strategy and real-world impact.
This requires more than strong planning. It requires alignment across evidence generation, stakeholder engagement, and execution to ensure that insights translate into meaningful decisions.
Acumetis supports teams in delivering end-to-end scientific strategy, from evidence generation through to execution, with a focus on continuity, clarity, and practical application.
Acumetis partners with life sciences organizations to translate complex clinical and real-world evidence into clear, decision-relevant strategies that support pricing, reimbursement, and access.
Key areas of focus
At MAPS EMEA, our discussions will center on:
- Maintaining alignment across the full evidence lifecycle
- Integrating evidence generation with stakeholder engagement
- Supporting consistent execution across global and local teams
- Translating scientific insight into decisions that inform access and adoption
- Navigating evolving requirements, including Joint Clinical Assessments
Featured session
Medical collaboration with Market Access for integrated evidence generation and Joint Clinical Assessments (JCA)
Kevin Asher, Partner and Practice Lead for Medical Affairs, will lead a plenary session exploring how Medical Affairs can coordinate evidence generation and cross-functional collaboration to support patient access.
Session details
Date: May 18th
Where to Find Us
- May 17–19th, 2026
- The Circle Convention Center in Zurich, Switzerland
- Speaker Session: Kevin Asher
Join our session to explore how evidence planning is evolving and what it means for cross-functional collaboration.
About Acumetis
Acumetis partners with life sciences organizations to navigate complex strategic, scientific, and commercial challenges across the product lifecycle.
We bring together medical, access, commercial, insights, and patient strategy into a coordinated path forward, building the knowledge and clarity that strengthen decision-making.
Our work spans Medical Affairs, Market Access, and Commercial Strategy, supporting teams in connecting evidence, engagement, and execution to drive meaningful outcomes.
At the core of our approach is a focus on reframing challenges, bringing strategic clarity, and creating critical connections that enable progress in practice.
Who You’ll Meet
Ali Lawrence
Principal
Ali brings extensive experience across global market access, value communication, and stakeholder engagement, supporting teams across the full asset lifecycle.
Kevin Asher
Partner and Practice Lead, Medical Affairs
Kevin brings experience across clinical practice, Medical Affairs leadership, and global strategy, with a focus on integrating scientific and cross-functional perspectives.
Schedule a meeting with the Acumetis team by contacting them directly.